Home

Red Blood Cell Lab
Meet our Staff
News
Licensing
FAQ

Laboratory Services
Routine Hemoglobinopathy
Molecular Assays
Special Hemoglobin Tests
Red Cell Function Tests



Advia 120 analysis
Reticulocytes
Erythropoietin
Blood flow
Ektacytometry
Oxygen Affinity
PS exposure
Red Cell survival
Hemostasis


Blood Analysis
Data Evaluation

Resource
Study Facilitation
Database Development
Storage
Assay Development

Hemoglobinopathies
Sickle Cell Disease
Thalassemia
Other Hemoglobinopathies

Red Cells
Red Cell Membranes
Red Cell Lipids
Red Cell Metabolism

Financial Policies
Contact us

Research tools

Human Erythropoeitin (Epo), the principal regulating factor of erythropoiesis, is a glycoprotein produced primarily by the kidney and is regulated by changes in oxygen availability. Hypoxia causes an increase in the level of Epo in circulation and a resultant increase in RBC production. Abnormally high concentrations of serum Epo may be observed in various pathological states including anemia, polycythemia, renal neoplasms, benign tumors, polycystic kidney disease, renal cysts, and hydronephrosis.

Click here for sample collection and shipping.

The Epo ELISA is a standard sandwich enzyme immunoassay allowing for the quantitative determination of human Epo concentration in either fresh or frozen EDTA plasma or serum without prior sample purification. This ELISA is for research use only, not for diagnostic or therapeutic procedures. The standard curve spans the range of 2.5-200.0 mIU/ml and the minimum detectable level is 0.6 mIU/mL. If specimens generate values higher than the highest standard, specimens are diluted and repeated. The normal range of Epo concentration in human serum and plasma is 3 - 17 mIU/mL.